Beyond Metabolic Health: The Emerging Frontier of Incretin Therapies in Addiction
Episode Summary
Emerging evidence suggests GLP-1 receptor agonists may reduce alcohol cravings and heavy drinking, offering a promising new treatment approach for alcohol use disorder, especially with obesity.